Published in BMC Cancer on November 21, 2013
Human papillomavirus prevalence and type-distribution in cervical glandular neoplasias: Results from a European multinational epidemiological study. Int J Cancer (2015) 0.84
Is cervical screening preventing adenocarcinoma and adenosquamous carcinoma of the cervix? Int J Cancer (2016) 0.79
Hypoxia-inducible miR-152 suppresses the expression of WNT1 and ERBB3, and inhibits the proliferation of cervical cancer cells. Exp Biol Med (Maywood) (2015) 0.75
Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med (2007) 15.40
Classification of papillomaviruses. Virology (2004) 14.16
Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol (2010) 9.86
Chapter 2: The burden of HPV-related cancers. Vaccine (2006) 7.70
Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J Clin Microbiol (1999) 6.45
Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication. Int J Cancer (2011) 5.43
The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years. J Infect Dis (2009) 5.09
The carcinogenicity of human papillomavirus types reflects viral evolution. Virology (2005) 4.72
Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women. J Natl Cancer Inst (2010) 4.20
Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. J Natl Cancer Inst (2006) 4.14
Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial. Lancet Oncol (2011) 3.98
Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline. Infect Agent Cancer (2009) 3.33
The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States--a 24-year population-based study. Gynecol Oncol (2000) 2.76
Age-specific prevalence of infection with human papillomavirus in females: a global review. J Adolesc Health (2008) 2.64
Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976-2000. Cancer (2004) 2.46
Incidence trends of adenocarcinoma of the cervix in 13 European countries. Cancer Epidemiol Biomarkers Prev (2005) 2.24
Changing rates of adenocarcinoma and adenosquamous carcinoma of the cervix in England. Lancet (2001) 2.05
Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinoma. Am J Pathol (2000) 1.97
A panel of immunohistochemical stains, including carcinoembryonic antigen, vimentin, and estrogen receptor, aids the distinction between primary endometrial and endocervical adenocarcinomas. Int J Gynecol Pathol (2002) 1.90
One virus, one lesion--individual components of CIN lesions contain a specific HPV type. J Pathol (2012) 1.67
Distinction between endometrial and endocervical adenocarcinoma: an immunohistochemical study. Int J Gynecol Pathol (2002) 1.63
International trends in the incidence of cervical cancer: I. Adenocarcinoma and adenosquamous cell carcinomas. Int J Cancer (1998) 1.56
Cervical cancer: effect of glandular cell type on prognosis, treatment, and survival. Obstet Gynecol (2003) 1.54
Differences in human papillomavirus type distribution in high-grade cervical intraepithelial neoplasia and invasive cervical cancer in Europe. Int J Cancer (2012) 1.48
Mortality trends for cervical squamous and adenocarcinoma in the United States. Relation to incidence and survival. Cancer (2005) 1.35
Adenocarcinoma: a unique cervical cancer. Gynecol Oncol (2009) 1.30
Adenocarcinoma as an independent risk factor for disease recurrence in patients with stage IB cervical carcinoma. Gynecol Oncol (1995) 1.29
Members of the human papillomavirus type 18 family (alpha-7 species) share a common association with adenocarcinoma of the cervix. Int J Cancer (2008) 1.21
Molecular mapping of high-grade cervical intraepithelial neoplasia shows etiological dominance of HPV16. Int J Cancer (2012) 1.21
Screening and adenocarcinoma of the cervix. Int J Cancer (2009) 1.19
Obesity as a potential risk factor for adenocarcinomas and squamous cell carcinomas of the uterine cervix. Cancer (2003) 1.19
Unusual endocervical adenocarcinomas: an immunohistochemical analysis with molecular detection of human papillomavirus. Am J Surg Pathol (2011) 1.17
Human papillomavirus type-distribution in cervical cancer in China: the importance of HPV 16 and 18. Cancer Causes Control (2009) 1.14
A comparison of adenocarcinoma and squamous cell carcinoma of the cervix. Obstet Gynecol (1991) 1.12
Cervical cancer in the Netherlands 1989-1998: Decrease of squamous cell carcinoma in older women, increase of adenocarcinoma in younger women. Int J Cancer (2005) 1.11
Absence of high-risk human papillomavirus (HPV) detection in endocervical adenocarcinoma with gastric morphology and phenotype. Am J Pathol (2010) 1.10
Adenocarcinomas of the uterine cervix: the epidemiology of an increasing problem. Epidemiol Rev (1993) 1.07
A comparison of prognoses of pathologic stage Ib adenocarcinoma and squamous cell carcinoma of the uterine cervix. Gynecol Oncol (2000) 1.04
A novel blueprint for 'top down' differentiation defines the cervical squamocolumnar junction during development, reproductive life, and neoplasia. J Pathol (2013) 1.00
Quantification of intracellular HPV E6/E7 mRNA expression increases the specificity and positive predictive value of cervical cancer screening compared to HPV DNA. Gynecol Oncol (2010) 0.92
Reproducibility of classification in non-squamous cell carcinomas of the uterine cervix. Gynecol Oncol (2003) 0.89
Comparison of real-time multiplex human papillomavirus (HPV) PCR assays with INNO-LiPA HPV genotyping extra assay. J Clin Microbiol (2010) 0.88
Pathological characteristics of cervical adenocarcinoma in a multi-center US-based study. Gynecol Oncol (2006) 0.87
Incidence and survival rate of women with cervical cancer in the Greater Amsterdam area. Br J Cancer (2003) 0.87
Prognosis of the adenocarcinoma of the cervix uteri: a comparative study. Gynecol Oncol (1989) 0.87
Evaluation of the performance of the novel PapilloCheck HPV genotyping test by comparison with two other genotyping systems and the HC2 test. J Med Virol (2010) 0.87
Prevalence and type distribution of human papillomavirus in cervical adenocarcinoma in Korean women. Gynecol Oncol (2013) 0.81
Detection of human papillomavirus in cervical cell specimens by hybrid capture and PCR with different primers. Acta Biochim Pol (2006) 0.81
Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet (2004) 8.09
Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet (2006) 7.83
Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer. Cancer Epidemiol Biomarkers Prev (2005) 3.40
Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis. Am J Epidemiol (2008) 2.91
Human papillomavirus type distribution in anal cancer and anal intraepithelial lesions. Int J Cancer (2009) 2.90
p16INK4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia. Am J Surg Pathol (2002) 2.73
Age-specific prevalence of infection with human papillomavirus in females: a global review. J Adolesc Health (2008) 2.64
Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS. Gastroenterology (2003) 2.39
Circulatory arrest versus cerebral perfusion during pulmonary endarterectomy surgery (PEACOG): a randomised controlled trial. Lancet (2011) 2.27
Distinctive clinical, psychological, and histological features of postinfective irritable bowel syndrome. Am J Gastroenterol (2003) 1.92
Systematic review of human papillomavirus prevalence in invasive penile cancer. Cancer Causes Control (2008) 1.89
Organization of human papillomavirus productive cycle during neoplastic progression provides a basis for selection of diagnostic markers. J Virol (2003) 1.79
One virus, one lesion--individual components of CIN lesions contain a specific HPV type. J Pathol (2012) 1.67
Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry. J Thorac Cardiovasc Surg (2011) 1.66
Rates of autoimmune diseases in Kaiser Permanente for use in vaccine adverse event safety studies. Vaccine (2009) 1.50
Differences in human papillomavirus type distribution in high-grade cervical intraepithelial neoplasia and invasive cervical cancer in Europe. Int J Cancer (2012) 1.48
Oncogenic human papillomavirus-infected immature metaplastic cells and cervical neoplasia. Am J Surg Pathol (2014) 1.46
Human papillomavirus type-distribution in vulvar and vaginal cancers and their associated precursors. Obstet Gynecol (2009) 1.45
Reversing LRP5-dependent osteoporosis and SOST deficiency-induced sclerosing bone disorders by altering WNT signaling activity. J Bone Miner Res (2014) 1.42
The Value of Endocervical Curettage in Addition to Biopsies in Women Referred to Colposcopy. J Low Genit Tract Dis (2015) 1.39
Age-specific prevalence of human papillomavirus infection in males: a global review. J Adolesc Health (2011) 1.37
Clinician's guide to human papillomavirus immunology: knowns and unknowns. Lancet Infect Dis (2009) 1.29
Evaluation of efficacy of community-based vs. institutional-based direct observed short-course treatment for the control of tuberculosis in Kilombero district, Tanzania. Trop Med Int Health (2003) 1.27
Patterns of persistent genital human papillomavirus infection among women worldwide: a literature review and meta-analysis. Int J Cancer (2012) 1.23
The occasional role of low-risk human papillomaviruses 6, 11, 42, 44, and 70 in anogenital carcinoma defined by laser capture microdissection/PCR methodology: results from a global study. Am J Surg Pathol (2013) 1.21
Rate and predictors of new genital warts claims and genital warts-related healthcare utilization among privately insured patients in the United States. Sex Transm Dis (2004) 1.20
Human papillomavirus type-distribution in cervical cancer in China: the importance of HPV 16 and 18. Cancer Causes Control (2009) 1.14
Polyphosphate kinase from activated sludge performing enhanced biological phosphorus removal. Appl Environ Microbiol (2002) 1.13
Helicobacter pylori mutants defective in RuvC Holliday junction resolvase display reduced macrophage survival and spontaneous clearance from the murine gastric mucosa. Infect Immun (2003) 1.11
The high comorbidity burden of the hepatitis C virus infected population in the United States. BMC Infect Dis (2012) 1.10
A systematic review to calculate background miscarriage rates using life table analysis. Birth Defects Res A Clin Mol Teratol (2012) 1.09
Excitation of rat colonic afferent fibres by 5-HT(3) receptors. J Physiol (2002) 1.07
The Papworth experience with the Levitronix CentriMag ventricular assist device. J Heart Lung Transplant (2008) 1.05
Trial of management of borderline and other low-grade abnormal smears (TOMBOLA): Trial design. Contemp Clin Trials (2006) 1.05
Polyphosphate kinase genes from full-scale activated sludge plants. Appl Microbiol Biotechnol (2007) 1.04
Persistence of an incident human papillomavirus infection and timing of cervical lesions in previously unexposed young women. Cancer Epidemiol Biomarkers Prev (2009) 1.03
Role of NT-proBNP and 6MWD in chronic thromboembolic pulmonary hypertension. Respir Med (2007) 1.00
Chronic hepatitis B virus infection in the Asia-Pacific region and Africa: review of disease progression. J Gastroenterol Hepatol (2005) 1.00
Family functioning and early learning practices in immigrant homes. Child Dev (2012) 1.00
Detection of rare and possibly carcinogenic human papillomavirus genotypes as single infections in invasive cervical cancer. J Pathol (2012) 0.97
Digestive and physiologic effects of a wheat bran extract, arabino-xylan-oligosaccharide, in breakfast cereal. Nutrition (2012) 0.96
Prevalence of human papillomavirus infection and associated risk factors in young women in Brazil, Canada, and the United States: a multicenter cross-sectional study. Int J Gynecol Pathol (2011) 0.96
Cervical human papillomavirus screening among older women. Emerg Infect Dis (2005) 0.96
Accuracy of SRM and power tap power monitoring systems for bicycling. Med Sci Sports Exerc (2004) 0.96
A review of evaluative studies of computer-based learning in nursing education. 2001. Nurse Educ Today (2005) 0.95
The physical demands of Super 14 rugby union. J Sci Med Sport (2011) 0.94
Factors affecting the rate of phosphocreatine resynthesis following intense exercise. Sports Med (2002) 0.94
Strategies for optimal expression of vaccine antigens from Taeniid cestode parasites in Escherichia coli. Mol Biotechnol (2011) 0.90
HPV-genotypes in high-grade intraepithelial cervical lesions in Danish women. Acta Obstet Gynecol Scand (2013) 0.90
Armed Forces occupational health--a review. Occup Med (Lond) (2009) 0.90
Comparison of outcomes from smoking and nonsmoking donors: thirteen-year experience. Ann Thorac Surg (2010) 0.90
Psychosocial issues for patients with ventricular assist devices: a qualitative pilot study. Am J Crit Care (2007) 0.89
Enhanced biological phosphorus removal from wastewater by biomass with different phosphorus contents, Part I: Experimental results and comparison with metabolic models. Water Environ Res (2004) 0.88
Refining the management of low-grade cervical abnormalities in the UK National Health Service and defining the potential for human papillomavirus testing: a commentary on emerging evidence. J Low Genit Tract Dis (2006) 0.88
Development of three PCR assays for the differentiation between Echinococcus shiquicus, E. granulosus (G1 genotype), and E. multilocularis DNA in the co-endemic region of Qinghai-Tibet plateau, China. Am J Trop Med Hyg (2013) 0.87
Demographic, behavioral, and knowledge factors associated with herpes simplex virus type 2 infection among men whose current female partner has genital herpes. Sex Transm Dis (2005) 0.86
Validity and reliability of GPS for measuring distance travelled in field-based team sports. J Sports Sci (2010) 0.86
Size matching in lung transplantation: an evidence-based review. J Heart Lung Transplant (2013) 0.86
Occlusion pressure analysis role in partitioning of pulmonary vascular resistance in CTEPH. Eur Respir J (2012) 0.86
Age-related decline in rectal mucosal lymphocytes and mast cells. Eur J Gastroenterol Hepatol (2004) 0.85
Substrain-specific differences in survival and osteonecrosis incidence in a mouse model. Comp Med (2012) 0.85
Familial aggregation of diabetes and hypertension in a case-control study of colorectal neoplasia. Am J Epidemiol (2002) 0.85
Attributing oncogenic human papillomavirus genotypes to high-grade cervical neoplasia: which type causes the lesion? Am J Surg Pathol (2015) 0.85
Applied physiology of rugby league. Sports Med (2008) 0.85
Atrial myxoma: a cardiocutaneous syndrome. Hosp Med (2004) 0.84
Physical activity of young children: a two-year follow-up. Phys Occup Ther Pediatr (2008) 0.84
A place to play: socioeconomic and spatial factors in children's physical activity. Aust Occup Ther J (2008) 0.83
Clostridium difficile in hip fracture patients: prevention, treatment and associated mortality. Injury (2009) 0.83
Influence of mixed liquor properties and aeration intensity on membrane fouling in a submerged membrane bioreactor at high mixed liquor suspended solids concentrations. Water Res (2007) 0.83
Exploring the meaning of, the barriers to and potential strategies for promoting physical activity among urban Indigenous Australians. Health Promot J Austr (2008) 0.82
Primary pulmonary artery sarcoma and coexisting chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med (2013) 0.82
Physical collisions and injury during professional rugby league skills training. J Sci Med Sport (2010) 0.82
The effect of organic loading on process performance and membrane fouling in a submerged membrane bioreactor treating municipal wastewater. Water Res (2006) 0.82
Prevalence and type distribution of human papillomavirus in cervical adenocarcinoma in Korean women. Gynecol Oncol (2013) 0.81
Dietary patterns in an ethnoculturally diverse population of young Canadian adults. Can J Diet Pract Res (2011) 0.81
Skill qualities as risk factors for contact injury in professional rugby league players. J Sports Sci (2012) 0.81
Mitochondrial disorders among infants exposed to HIV and antiretroviral therapy. Drug Saf (2007) 0.81
Diabetes-specific nutrition algorithm: a transcultural program to optimize diabetes and prediabetes care. Curr Diab Rep (2012) 0.80
A time-motion analysis of professional rugby league match-play. J Sports Sci (2009) 0.80
Impact of acute weight loss and/or thermal stress on rowing ergometer performance. Med Sci Sports Exerc (2005) 0.80
Toxicity of mycophenolate mofetil in patients with inflammatory bowel disease. Inflamm Bowel Dis (2002) 0.80
Knowledge of and preferred sources of assistance for physical activity in a sample of urban Indigenous Australians. Int J Behav Nutr Phys Act (2008) 0.79
E4 antibodies facilitate detection and type-assignment of active HPV infection in cervical disease. PLoS One (2012) 0.79
Preparation of former heavyweight oarsmen to compete as lightweight rowers over 16 weeks: three case studies. Int J Sport Nutr Exerc Metab (2006) 0.79
Enhanced biological phosphorus removal from wastewater by biomass with different phosphorus contents, Part II: Anaerobic adenosine triphosphate utilization and acetate uptake rates. Water Environ Res (2004) 0.79
HLA-B*5701 and abacavir hypersensitivity. Pharmacogenetics (2004) 0.79
Repeated high-intensity exercise in professional rugby union. J Sports Sci (2011) 0.79
Tackling in a professional rugby league. J Strength Cond Res (2011) 0.78
Seroprevalence of herpes simplex virus 1 and 2 and correlates of infection in Israel. J Infect (2005) 0.78
Laser capture microdissection shows HPV11 as both a causal and a coincidental infection in cervical cancer specimens with multiple HPV types. Histopathology (2013) 0.78
Body-mass management of Australian lightweight rowers prior to and during competition. Med Sci Sports Exerc (2005) 0.78
Detection and quantitation of HPV gene expression using real-time PCR. Methods Mol Med (2005) 0.78
Isolation of Toxoplasma gondii from the brain of a dog in Australia and its biological and molecular characterization. Vet Parasitol (2009) 0.78
Enhanced biological phosphorus removal from wastewater by biomass with different phosphorus contents, Part III: Anaerobic sources of reducing equivalents. Water Environ Res (2004) 0.78
Images in clinical medicine. An unusual case of pulmonary embolism. N Engl J Med (2005) 0.78
Influence of nutrient intake after weigh-in on lightweight rowing performance. Med Sci Sports Exerc (2007) 0.77
Recurrent diabetic ketoacidosis after changing pen devices for insulin injection. BMJ (2006) 0.77
HPV genotypes in invasive cervical cancer in Danish women. Acta Obstet Gynecol Scand (2013) 0.77